ATH-1105 – A next-generation, novel, orally administered, small molecule drug candidate in development for the potential treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative ...

A fundraiser has been launched for Will Vess, a 57-year-old retired United States Air Force veteran who was recently ...

Her husband, Scott Sessa, said that her death, in a hospital, was caused by complications of amyotrophic lateral sclerosis ...

Scientists are working on a way to restore the production of a protein that is essential for communication in the brain and ...

The condition is a rapidly progressive neurodegenerative disorder leading to wasting, paralysis, and eventual death from ...

The FDA initially halted the trials on 16 October after a patient in the Phase II trial (NCT05519839) of the CIC vaccine ...

John Rzeznik, Brian Fallon, Pete Steinkopf, Dramarama, Willie Nile, Joe Grushecky and the Houserockers and more set for Bob's Birthday Bash.

CAMBRIDGE, Massachusetts and TORONTO, Ontario, Nov. 12, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage ...

Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.

Friends and family gathered on Friday night to bid farewell to community leader and nature promoter Omar Gallardo with an ...

A surprise finding by two independent research teams and a venture capital mega-round have birthed a biotech looking to treat ...